Ignite Creation Date:
2024-05-06 @ 8:21 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06340165
Status:
RECRUITING
Last Update Posted:
2024-04-01
First Post:
2024-01-01
Brief Title:
A Real-world Efficacy and Safety Study of Amlotinib for HER2-negative Advanced Breast Cancer
Sponsor:
The First Hospital of Jilin University
Organization:
The First Hospital of Jilin University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-02-04
Start Date Type:
ACTUAL
Primary Completion Date:
2025-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-06
Completion Date Type:
ESTIMATED
First Submit Date:
2024-01-01
First Submit QC Date:
March 29 2024
Study First Post Date:
2024-04-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-29
Last Update Post Date:
2024-04-01
Last Update Post Date Type:
ACTUAL